コデイン麻薬の世界市場見通し2023年-2029年

◆英語タイトル:Codeine Narcotic Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書(MMG23LY8426)◆商品コード:MMG23LY8426
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2023年7月(※2025年版があります。お問い合わせください。)
◆ページ数:113
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥468,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥608,400見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥702,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Codeine Narcotic Market 調査レポートは次の情報を含め、グローバルにおけるのコデイン麻薬市場規模と予測を収録しています。・世界のコデイン麻薬市場:売上、2018年-2023年、2024年-2029年
・世界のコデイン麻薬市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のコデイン麻薬市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「単一成分コデイン」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

コデイン麻薬のグローバル主要企業は、Taiji、 Mallinckrodt、 TEVA、 Johnson & Johnson、 Medreich、 Sanofi Aventis、 Cipla、 Hikma、 Pharmaceutical Associates、 Novartis、 Apotex、 Mylan、 Aristo Pharma GmbH、 Lannett Company、 Laboratoire Rivaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、コデイン麻薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のコデイン麻薬市場:タイプ別、2018年-2023年、2024年-2029年
世界のコデイン麻薬市場:タイプ別市場シェア、2022年
・単一成分コデイン、複合成分医薬品

世界のコデイン麻薬市場:用途別、2018年-2023年、2024年-2029年
世界のコデイン麻薬市場:用途別市場シェア、2022年
・麻薬性鎮痛薬、鎮咳薬、その他

世界のコデイン麻薬市場:地域・国別、2018年-2023年、2024年-2029年
世界のコデイン麻薬市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるコデイン麻薬のグローバル売上、2018年-2023年
・主要企業におけるコデイン麻薬のグローバル売上シェア、2022年
・主要企業におけるコデイン麻薬のグローバル販売量、2018年-2023年
・主要企業におけるコデイン麻薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Taiji、 Mallinckrodt、 TEVA、 Johnson & Johnson、 Medreich、 Sanofi Aventis、 Cipla、 Hikma、 Pharmaceutical Associates、 Novartis、 Apotex、 Mylan、 Aristo Pharma GmbH、 Lannett Company、 Laboratoire Riva

*************************************************************

・調査・分析レポートの概要
コデイン麻薬市場の定義
市場セグメント
世界のコデイン麻薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のコデイン麻薬市場規模
世界のコデイン麻薬市場規模:2022年 VS 2029年
世界のコデイン麻薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのコデイン麻薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のコデイン麻薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:単一成分コデイン、複合成分医薬品
コデイン麻薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:麻薬性鎮痛薬、鎮咳薬、その他
コデイン麻薬の用途別グローバル売上・予測

・地域別市場分析
地域別コデイン麻薬市場規模 2022年と2029年
地域別コデイン麻薬売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報(企業概要、事業概要、主要製品、売上、ニュースなど)
Taiji、 Mallinckrodt、 TEVA、 Johnson & Johnson、 Medreich、 Sanofi Aventis、 Cipla、 Hikma、 Pharmaceutical Associates、 Novartis、 Apotex、 Mylan、 Aristo Pharma GmbH、 Lannett Company、 Laboratoire Riva
...

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
This report aims to provide a comprehensive presentation of the global market for Codeine Narcotic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Codeine Narcotic. This report contains market size and forecasts of Codeine Narcotic in global, including the following market information:
Global Codeine Narcotic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Codeine Narcotic Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Codeine Narcotic companies in 2022 (%)
The global Codeine Narcotic market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Single-ingredient Codeine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Codeine Narcotic include Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma and Pharmaceutical Associates, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Codeine Narcotic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Codeine Narcotic Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Codeine Narcotic Market Segment Percentages, by Type, 2022 (%)
Single-ingredient Codeine
Multi-ingredient Medications
Global Codeine Narcotic Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Codeine Narcotic Market Segment Percentages, by Application, 2022 (%)
Narcotic Analgesic
Antitussive
Others
Global Codeine Narcotic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Codeine Narcotic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Codeine Narcotic revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Codeine Narcotic revenues share in global market, 2022 (%)
Key companies Codeine Narcotic sales in global market, 2018-2023 (Estimated), (Units)
Key companies Codeine Narcotic sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Outline of Major Chapters:
Chapter 1: Introduces the definition of Codeine Narcotic, market overview.
Chapter 2: Global Codeine Narcotic market size in revenue and volume.
Chapter 3: Detailed analysis of Codeine Narcotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Codeine Narcotic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Codeine Narcotic capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Codeine Narcotic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Codeine Narcotic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Codeine Narcotic Overall Market Size
2.1 Global Codeine Narcotic Market Size: 2022 VS 2029
2.2 Global Codeine Narcotic Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Codeine Narcotic Sales: 2018-2029
3 Company Landscape
3.1 Top Codeine Narcotic Players in Global Market
3.2 Top Global Codeine Narcotic Companies Ranked by Revenue
3.3 Global Codeine Narcotic Revenue by Companies
3.4 Global Codeine Narcotic Sales by Companies
3.5 Global Codeine Narcotic Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Codeine Narcotic Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Codeine Narcotic Product Type
3.8 Tier 1, Tier 2 and Tier 3 Codeine Narcotic Players in Global Market
3.8.1 List of Global Tier 1 Codeine Narcotic Companies
3.8.2 List of Global Tier 2 and Tier 3 Codeine Narcotic Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Codeine Narcotic Market Size Markets, 2022 & 2029
4.1.2 Single-ingredient Codeine
4.1.3 Multi-ingredient Medications
4.2 By Type – Global Codeine Narcotic Revenue & Forecasts
4.2.1 By Type – Global Codeine Narcotic Revenue, 2018-2023
4.2.2 By Type – Global Codeine Narcotic Revenue, 2024-2029
4.2.3 By Type – Global Codeine Narcotic Revenue Market Share, 2018-2029
4.3 By Type – Global Codeine Narcotic Sales & Forecasts
4.3.1 By Type – Global Codeine Narcotic Sales, 2018-2023
4.3.2 By Type – Global Codeine Narcotic Sales, 2024-2029
4.3.3 By Type – Global Codeine Narcotic Sales Market Share, 2018-2029
4.4 By Type – Global Codeine Narcotic Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Codeine Narcotic Market Size, 2022 & 2029
5.1.2 Narcotic Analgesic
5.1.3 Antitussive
5.1.4 Others
5.2 By Application – Global Codeine Narcotic Revenue & Forecasts
5.2.1 By Application – Global Codeine Narcotic Revenue, 2018-2023
5.2.2 By Application – Global Codeine Narcotic Revenue, 2024-2029
5.2.3 By Application – Global Codeine Narcotic Revenue Market Share, 2018-2029
5.3 By Application – Global Codeine Narcotic Sales & Forecasts
5.3.1 By Application – Global Codeine Narcotic Sales, 2018-2023
5.3.2 By Application – Global Codeine Narcotic Sales, 2024-2029
5.3.3 By Application – Global Codeine Narcotic Sales Market Share, 2018-2029
5.4 By Application – Global Codeine Narcotic Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Codeine Narcotic Market Size, 2022 & 2029
6.2 By Region – Global Codeine Narcotic Revenue & Forecasts
6.2.1 By Region – Global Codeine Narcotic Revenue, 2018-2023
6.2.2 By Region – Global Codeine Narcotic Revenue, 2024-2029
6.2.3 By Region – Global Codeine Narcotic Revenue Market Share, 2018-2029
6.3 By Region – Global Codeine Narcotic Sales & Forecasts
6.3.1 By Region – Global Codeine Narcotic Sales, 2018-2023
6.3.2 By Region – Global Codeine Narcotic Sales, 2024-2029
6.3.3 By Region – Global Codeine Narcotic Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Codeine Narcotic Revenue, 2018-2029
6.4.2 By Country – North America Codeine Narcotic Sales, 2018-2029
6.4.3 US Codeine Narcotic Market Size, 2018-2029
6.4.4 Canada Codeine Narcotic Market Size, 2018-2029
6.4.5 Mexico Codeine Narcotic Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Codeine Narcotic Revenue, 2018-2029
6.5.2 By Country – Europe Codeine Narcotic Sales, 2018-2029
6.5.3 Germany Codeine Narcotic Market Size, 2018-2029
6.5.4 France Codeine Narcotic Market Size, 2018-2029
6.5.5 U.K. Codeine Narcotic Market Size, 2018-2029
6.5.6 Italy Codeine Narcotic Market Size, 2018-2029
6.5.7 Russia Codeine Narcotic Market Size, 2018-2029
6.5.8 Nordic Countries Codeine Narcotic Market Size, 2018-2029
6.5.9 Benelux Codeine Narcotic Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Codeine Narcotic Revenue, 2018-2029
6.6.2 By Region – Asia Codeine Narcotic Sales, 2018-2029
6.6.3 China Codeine Narcotic Market Size, 2018-2029
6.6.4 Japan Codeine Narcotic Market Size, 2018-2029
6.6.5 South Korea Codeine Narcotic Market Size, 2018-2029
6.6.6 Southeast Asia Codeine Narcotic Market Size, 2018-2029
6.6.7 India Codeine Narcotic Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Codeine Narcotic Revenue, 2018-2029
6.7.2 By Country – South America Codeine Narcotic Sales, 2018-2029
6.7.3 Brazil Codeine Narcotic Market Size, 2018-2029
6.7.4 Argentina Codeine Narcotic Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Codeine Narcotic Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Codeine Narcotic Sales, 2018-2029
6.8.3 Turkey Codeine Narcotic Market Size, 2018-2029
6.8.4 Israel Codeine Narcotic Market Size, 2018-2029
6.8.5 Saudi Arabia Codeine Narcotic Market Size, 2018-2029
6.8.6 UAE Codeine Narcotic Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Taiji
7.1.1 Taiji Company Summary
7.1.2 Taiji Business Overview
7.1.3 Taiji Codeine Narcotic Major Product Offerings
7.1.4 Taiji Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.1.5 Taiji Key News & Latest Developments
7.2 Mallinckrodt
7.2.1 Mallinckrodt Company Summary
7.2.2 Mallinckrodt Business Overview
7.2.3 Mallinckrodt Codeine Narcotic Major Product Offerings
7.2.4 Mallinckrodt Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.2.5 Mallinckrodt Key News & Latest Developments
7.3 TEVA
7.3.1 TEVA Company Summary
7.3.2 TEVA Business Overview
7.3.3 TEVA Codeine Narcotic Major Product Offerings
7.3.4 TEVA Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.3.5 TEVA Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Codeine Narcotic Major Product Offerings
7.4.4 Johnson & Johnson Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Medreich
7.5.1 Medreich Company Summary
7.5.2 Medreich Business Overview
7.5.3 Medreich Codeine Narcotic Major Product Offerings
7.5.4 Medreich Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.5.5 Medreich Key News & Latest Developments
7.6 Sanofi Aventis
7.6.1 Sanofi Aventis Company Summary
7.6.2 Sanofi Aventis Business Overview
7.6.3 Sanofi Aventis Codeine Narcotic Major Product Offerings
7.6.4 Sanofi Aventis Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.6.5 Sanofi Aventis Key News & Latest Developments
7.7 Cipla
7.7.1 Cipla Company Summary
7.7.2 Cipla Business Overview
7.7.3 Cipla Codeine Narcotic Major Product Offerings
7.7.4 Cipla Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.7.5 Cipla Key News & Latest Developments
7.8 Hikma
7.8.1 Hikma Company Summary
7.8.2 Hikma Business Overview
7.8.3 Hikma Codeine Narcotic Major Product Offerings
7.8.4 Hikma Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.8.5 Hikma Key News & Latest Developments
7.9 Pharmaceutical Associates
7.9.1 Pharmaceutical Associates Company Summary
7.9.2 Pharmaceutical Associates Business Overview
7.9.3 Pharmaceutical Associates Codeine Narcotic Major Product Offerings
7.9.4 Pharmaceutical Associates Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.9.5 Pharmaceutical Associates Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Codeine Narcotic Major Product Offerings
7.10.4 Novartis Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Apotex
7.11.1 Apotex Company Summary
7.11.2 Apotex Codeine Narcotic Business Overview
7.11.3 Apotex Codeine Narcotic Major Product Offerings
7.11.4 Apotex Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.11.5 Apotex Key News & Latest Developments
7.12 Mylan
7.12.1 Mylan Company Summary
7.12.2 Mylan Codeine Narcotic Business Overview
7.12.3 Mylan Codeine Narcotic Major Product Offerings
7.12.4 Mylan Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.12.5 Mylan Key News & Latest Developments
7.13 Aristo Pharma GmbH
7.13.1 Aristo Pharma GmbH Company Summary
7.13.2 Aristo Pharma GmbH Codeine Narcotic Business Overview
7.13.3 Aristo Pharma GmbH Codeine Narcotic Major Product Offerings
7.13.4 Aristo Pharma GmbH Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.13.5 Aristo Pharma GmbH Key News & Latest Developments
7.14 Lannett Company
7.14.1 Lannett Company Company Summary
7.14.2 Lannett Company Business Overview
7.14.3 Lannett Company Codeine Narcotic Major Product Offerings
7.14.4 Lannett Company Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.14.5 Lannett Company Key News & Latest Developments
7.15 Laboratoire Riva
7.15.1 Laboratoire Riva Company Summary
7.15.2 Laboratoire Riva Business Overview
7.15.3 Laboratoire Riva Codeine Narcotic Major Product Offerings
7.15.4 Laboratoire Riva Codeine Narcotic Sales and Revenue in Global (2018-2023)
7.15.5 Laboratoire Riva Key News & Latest Developments
8 Global Codeine Narcotic Production Capacity, Analysis
8.1 Global Codeine Narcotic Production Capacity, 2018-2029
8.2 Codeine Narcotic Production Capacity of Key Manufacturers in Global Market
8.3 Global Codeine Narcotic Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Codeine Narcotic Supply Chain Analysis
10.1 Codeine Narcotic Industry Value Chain
10.2 Codeine Narcotic Upstream Market
10.3 Codeine Narcotic Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Codeine Narcotic Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Codeine Narcotic in Global Market
Table 2. Top Codeine Narcotic Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Codeine Narcotic Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Codeine Narcotic Revenue Share by Companies, 2018-2023
Table 5. Global Codeine Narcotic Sales by Companies, (Units), 2018-2023
Table 6. Global Codeine Narcotic Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Codeine Narcotic Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Codeine Narcotic Product Type
Table 9. List of Global Tier 1 Codeine Narcotic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Codeine Narcotic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Codeine Narcotic Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Codeine Narcotic Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Codeine Narcotic Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Codeine Narcotic Sales (Units), 2018-2023
Table 15. By Type - Global Codeine Narcotic Sales (Units), 2024-2029
Table 16. By Application – Global Codeine Narcotic Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Codeine Narcotic Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Codeine Narcotic Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Codeine Narcotic Sales (Units), 2018-2023
Table 20. By Application - Global Codeine Narcotic Sales (Units), 2024-2029
Table 21. By Region – Global Codeine Narcotic Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Codeine Narcotic Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Codeine Narcotic Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Codeine Narcotic Sales (Units), 2018-2023
Table 25. By Region - Global Codeine Narcotic Sales (Units), 2024-2029
Table 26. By Country - North America Codeine Narcotic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Codeine Narcotic Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Codeine Narcotic Sales, (Units), 2018-2023
Table 29. By Country - North America Codeine Narcotic Sales, (Units), 2024-2029
Table 30. By Country - Europe Codeine Narcotic Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Codeine Narcotic Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Codeine Narcotic Sales, (Units), 2018-2023
Table 33. By Country - Europe Codeine Narcotic Sales, (Units), 2024-2029
Table 34. By Region - Asia Codeine Narcotic Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Codeine Narcotic Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Codeine Narcotic Sales, (Units), 2018-2023
Table 37. By Region - Asia Codeine Narcotic Sales, (Units), 2024-2029
Table 38. By Country - South America Codeine Narcotic Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Codeine Narcotic Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Codeine Narcotic Sales, (Units), 2018-2023
Table 41. By Country - South America Codeine Narcotic Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Codeine Narcotic Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Codeine Narcotic Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Codeine Narcotic Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Codeine Narcotic Sales, (Units), 2024-2029
Table 46. Taiji Company Summary
Table 47. Taiji Codeine Narcotic Product Offerings
Table 48. Taiji Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Taiji Key News & Latest Developments
Table 50. Mallinckrodt Company Summary
Table 51. Mallinckrodt Codeine Narcotic Product Offerings
Table 52. Mallinckrodt Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Mallinckrodt Key News & Latest Developments
Table 54. TEVA Company Summary
Table 55. TEVA Codeine Narcotic Product Offerings
Table 56. TEVA Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. TEVA Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Codeine Narcotic Product Offerings
Table 60. Johnson & Johnson Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Medreich Company Summary
Table 63. Medreich Codeine Narcotic Product Offerings
Table 64. Medreich Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Medreich Key News & Latest Developments
Table 66. Sanofi Aventis Company Summary
Table 67. Sanofi Aventis Codeine Narcotic Product Offerings
Table 68. Sanofi Aventis Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Sanofi Aventis Key News & Latest Developments
Table 70. Cipla Company Summary
Table 71. Cipla Codeine Narcotic Product Offerings
Table 72. Cipla Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Cipla Key News & Latest Developments
Table 74. Hikma Company Summary
Table 75. Hikma Codeine Narcotic Product Offerings
Table 76. Hikma Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Hikma Key News & Latest Developments
Table 78. Pharmaceutical Associates Company Summary
Table 79. Pharmaceutical Associates Codeine Narcotic Product Offerings
Table 80. Pharmaceutical Associates Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Pharmaceutical Associates Key News & Latest Developments
Table 82. Novartis Company Summary
Table 83. Novartis Codeine Narcotic Product Offerings
Table 84. Novartis Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Novartis Key News & Latest Developments
Table 86. Apotex Company Summary
Table 87. Apotex Codeine Narcotic Product Offerings
Table 88. Apotex Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Apotex Key News & Latest Developments
Table 90. Mylan Company Summary
Table 91. Mylan Codeine Narcotic Product Offerings
Table 92. Mylan Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Mylan Key News & Latest Developments
Table 94. Aristo Pharma GmbH Company Summary
Table 95. Aristo Pharma GmbH Codeine Narcotic Product Offerings
Table 96. Aristo Pharma GmbH Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Aristo Pharma GmbH Key News & Latest Developments
Table 98. Lannett Company Company Summary
Table 99. Lannett Company Codeine Narcotic Product Offerings
Table 100. Lannett Company Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Lannett Company Key News & Latest Developments
Table 102. Laboratoire Riva Company Summary
Table 103. Laboratoire Riva Codeine Narcotic Product Offerings
Table 104. Laboratoire Riva Codeine Narcotic Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Laboratoire Riva Key News & Latest Developments
Table 106. Codeine Narcotic Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 107. Global Codeine Narcotic Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Codeine Narcotic Production by Region, 2018-2023 (Units)
Table 109. Global Codeine Narcotic Production by Region, 2024-2029 (Units)
Table 110. Codeine Narcotic Market Opportunities & Trends in Global Market
Table 111. Codeine Narcotic Market Drivers in Global Market
Table 112. Codeine Narcotic Market Restraints in Global Market
Table 113. Codeine Narcotic Raw Materials
Table 114. Codeine Narcotic Raw Materials Suppliers in Global Market
Table 115. Typical Codeine Narcotic Downstream
Table 116. Codeine Narcotic Downstream Clients in Global Market
Table 117. Codeine Narcotic Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Codeine Narcotic Segment by Type in 2022
Figure 2. Codeine Narcotic Segment by Application in 2022
Figure 3. Global Codeine Narcotic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Codeine Narcotic Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Codeine Narcotic Revenue, 2018-2029 (US$, Mn)
Figure 7. Codeine Narcotic Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Codeine Narcotic Revenue in 2022
Figure 9. By Type - Global Codeine Narcotic Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Codeine Narcotic Revenue Market Share, 2018-2029
Figure 11. By Type - Global Codeine Narcotic Sales Market Share, 2018-2029
Figure 12. By Type - Global Codeine Narcotic Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Codeine Narcotic Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Codeine Narcotic Revenue Market Share, 2018-2029
Figure 15. By Application - Global Codeine Narcotic Sales Market Share, 2018-2029
Figure 16. By Application - Global Codeine Narcotic Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Codeine Narcotic Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Codeine Narcotic Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Codeine Narcotic Revenue Market Share, 2018-2029
Figure 20. By Region - Global Codeine Narcotic Sales Market Share, 2018-2029
Figure 21. By Country - North America Codeine Narcotic Revenue Market Share, 2018-2029
Figure 22. By Country - North America Codeine Narcotic Sales Market Share, 2018-2029
Figure 23. US Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Codeine Narcotic Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Codeine Narcotic Sales Market Share, 2018-2029
Figure 28. Germany Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 29. France Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Codeine Narcotic Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Codeine Narcotic Sales Market Share, 2018-2029
Figure 37. China Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 41. India Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Codeine Narcotic Revenue Market Share, 2018-2029
Figure 43. By Country - South America Codeine Narcotic Sales Market Share, 2018-2029
Figure 44. Brazil Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Codeine Narcotic Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Codeine Narcotic Sales Market Share, 2018-2029
Figure 48. Turkey Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Codeine Narcotic Revenue, (US$, Mn), 2018-2029
Figure 52. Global Codeine Narcotic Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Codeine Narcotic by Region, 2022 VS 2029
Figure 54. Codeine Narcotic Industry Value Chain
Figure 55. Marketing Channels

※参考情報

コデイン麻薬は、オピオイドの一種として広く知られる鎮痛薬であり、主に軽度から中等度の痛みの緩和に使用されます。オピオイドは、オピウムポピーから抽出されるアルカロイドであり、神経系に作用して痛覚を抑制します。コデインはその中でも特に、体内でメタンフェタミンに変換される過程を経て鎮痛効果を発揮します。このため、コデインはしばしば鎮痛薬や咳止め薬として使用されますが、乱用のリスクも伴います。

コデインの特徴としては、まずその作用の穏やかさが挙げられます。モルヒネなどの他のオピオイドに比べて、痛みの管理能力は劣りますが、軽度な痛みの管理には適しています。コデインは、中枢神経系に作用し、痛みの感覚を軽減するだけでなく、同時に咳を抑える作用も持っています。そのため、呼吸器系に関連する症状を持つ患者に対しても有用な薬剤です。

コデインにはいくつかの種類があります。一般的には、単独で使用されるコデイン製剤と、他の薬剤と併用されるコデイン配合薬があります。たとえば、アセトアミノフェンやイブプロフェンと組み合わせた製剤は、鎮痛効果を高めるためによく用いられます。これらの製剤は、医療機関で処方されることが多く、患者の症状や必要に応じて選ばれます。

コデインの主な用途は、軽度から中等度の痛みの軽減、特に手術後の痛みや頭痛、筋肉痛、関節痛などに対して広く使用されます。また、咳止め薬としても用いられており、特に乾いた咳や慢性的な咳の緩和に効果を示します。これにより、風邪やインフルエンザ、アレルギー性の咳などさまざまな疾患に対する症状緩和が期待されます。

しかし、コデインの使用にあたっては注意が必要です。特に、長期間にわたる使用や、高用量での使用は依存症や耐性のリスクを増加させる可能性があります。依存症になると、身体的および精神的な健康に深刻な影響を及ぼすことがあります。そのため、医師の指導の下で適切な用法・用量を守ることが重要です。また、コデインを含む薬剤は、妊娠中や授乳中の女性には使用が制限される場合があるため、注意が必要です。

関連技術としては、コデインの製剤技術や、オピオイドの代謝に関する研究が進められています。コデインの効果や副作用を最小限に抑えるための新しい製剤技術の開発や、患者ごとの適切な投与量の決定を支援する個別化医療が進行中です。また、オピオイド依存症を防ぐための取り組みも行われており、非オピオイド系の鎮痛剤や、他の治療法と組み合わせた新しいアプローチが模索されています。

さらに、コデインの使用に関する規制も強化されつつあります。多くの国では、コデインを含む医薬品に対する処方や販売に対する基準が厳格に定められており、乱用を防ぐための啓発活動も行われています。医療従事者に対する教育や、患者に対しての情報提供が重要です。

このように、コデイン麻薬はその特性や用途、関連技術において多岐にわたる影響を持つ医薬品であり、正しい使い方とリスク管理が求められます。適切に使用すれば、患者にとって大変有用な薬剤となりますが、乱用や依存症のリスクを常に意識し、医療者と患者が連携して安全な使用を心がけることが必要です。将来的には、より安全で効果的な鎮痛治療法や、コデインに代わる新しい薬剤が登場することが期待されます。


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ コデイン麻薬の世界市場見通し2023年-2029年(Codeine Narcotic Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆